Circassia lowers earnings breakeven point after restructuring; annual revenue falls | 12 January 2021
12 January 2021 | 08:19am StockMarketWire.com - Medical device company Circassia lowered its earnings breakeven point for its Niox business on margin improvements after largely completing restructuring plan. But annual revenue fell on the impact of the global lockdown. For the continuing Niox business for the year ended 31 December 2020, revenue fell to £23.9 million from £34.6 million. 'The global lockdown which commenced at the start of the second quarter significantly affected testing volumes in the clinical business and delayed studies for our research customers, the company said....
Source: stockmarketwire.com